Provided by Tiger Trade Technology Pte. Ltd.

Corgi NVO 2x Daily ETF

19.01
+0.38532.07%
Post-market: 18.62-0.3853-2.03%16:10 EDT
Volume:15
Turnover:284
Market Cap:285.14K
PE:- -
High:19.01
Open:18.62
Low:19.01
Close:18.62
52wk High:27.19
52wk Low:18.62
Shares:15.00K
Float Shares:15.00K
Volume Ratio:0.48
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novo Nordisk is Dropping Some Weight. it Still Faces a Bigger Challenge.

Dow Jones
·
5 hours ago

Novo Nordisk A/S Series B Stock Rises Monday, Outperforms Market

Dow Jones
·
8 hours ago

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Yesterday

Novo Nordisk Kept at Hold as Analyst Maintains $47 Price Target Amid Strategic Uncertainty

TIPRANKS
·
Yesterday

Data Retention Terms Prompt Restraints on AI Model Use for Sensitive Operations

Deep News
·
Yesterday

Novo Signals New Direction of Travel with Rebrand

Dow Jones
·
Yesterday

AstraZeneca's Breast Cancer Drug Etcamah Hits A Phase 3 Setback, Clouding Billions In Potential Sales

Options & Short Sell
·
Yesterday

Novo Nordisk to Rebrand as Novo

Dow Jones
·
Yesterday

GE HealthCare Plans $1 Billion Sofie Deal To Tap Fast-Growing Radiopharmaceuticals Market

Options & Short Sell
·
Yesterday

Novo Nordisk Stock Slides as GLP-1 Fears Mount

TIPRANKS
·
Sep 12

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12

ETF Weekly | MSTZ, SMST Surge 17%; AMUU, AMDL Jump 16%; USO Advances 9%; Oil Theme Gains

ETF Weekly
·
Sep 12

Sector Update: Healthcare

MT Newswires Live
·
Sep 12

Novo Nordisk Shares Fall After Morgan Stanley Downgrade

MT Newswires Live
·
Sep 12

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 12

U.S. Stocks on the MOVE-Novo Nordisk, Oracle, Adobe

Reuters
·
Sep 11

Novo Nordisk Stock (NVO) Falls After Morgan Stanley’s Sell Call on Market Share Loss to Eli Lilly, Patent Cliff

TIPRANKS
·
Sep 11

Novo Nordisk downgraded to Underweight from Equal Weight at Morgan Stanley

TIPRANKS
·
Sep 11

Morgan Stanley downgrades Novo Nordisk (0QIU) to a Sell

TIPRANKS
·
Sep 11

MS Cuts Novo Nordisk on Growth Prospects, Patent Expiry Risks

Reuters
·
Sep 11